PATENT CLAIM ANALYSIS

Application Number: 15927920
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "275000"]

Abstract:
The present disclosure relates generally to LRRK2 inhibitors, or a pharmaceutically acceptable salt, deuterated analog, prodrug, tautomer, stereoisomer, or mixture of stereoisomers thereof, and methods of making and using thereof.

Claim (Index 21):
A pharmaceutical composition comprising a compound of Table 1A, Table 1B, Table 2A or Table 2B, or a pharmaceutically acceptable salt, deuterated analog, prodrug, tautomer, stereoisomer, or a mixture of stereoisomers thereof, and a pharmaceutically acceptable carrier, diluent, or excipient.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13687421', '14531349', '13292668', '13687441', '13687429']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7385788653593712
- 35 USC 102 Novelty (BERT): 0.5156611503007046
- Combined Prediction Score: 0.7162870938535046
- Mean Citation Score: 253.890068
- Max Citation Score: 262.75366
- Similarity Product: 171.82947238959076

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test